Sign in

Back to the bill

91st General Assembly · Funnel one-pager · Monday, November 9, 2026

HF 14: Relating to the controlled substance crystalline polymorph psilocybin

Became HF 383 · Its progress continues under the new number.

What it does

This bill relates to the controlled substance crystalline polymorph psilocybin.201(4)(s)).204(4), a drug that contains the pharmaceutical composition of crystalline polymorph psilocybin shall be immediately removed from schedule I upon its approval by the United States food and drug administration and rescheduled based upon the recommendations of the United States food and drug administration and its listing in the federal Controlled Substances Act. it shall be lawful to prescribe, distribute, and market the pharmaceutical composition of crystalline polymorph psilocybin.

Sponsors

Rep. Ann Meyer (R)

Cost

No fiscal note

House subcommittee · named January 22, 2025

  • Rep. Brett Barker (R) · brett.barker@legis.iowa.gov
  • Rep. Michael R. Bergan (R) · michael.bergan@legis.iowa.gov
  • Rep. Josh Turek (D) · josh.turek@legis.iowa.gov

Lobbying · 4 for, 0 against

For: Compass Pathways; Dr. Tanja Garrison; Iowa Integrated Health Planning and Advisory Council; Mindspring Mental Health Alliance

In plain words

  1. January 14, 2025Filed in the House and sent to the Health and Human Services committee
  2. January 22, 2025House subcommittee named: Barker, Bergan and Turek
  3. February 6, 2025Subcommittee recommended passing it
  4. February 11, 2025Approved by the House committee
  5. February 11, 2025Committee vote: 20–0
  6. February 13, 2025Approved by the House committee, and given a new number: HF 383
  7. February 24, 2025Withdrawn

From public records at legis.iowa.gov, compiled by Funnel (iowafunnel.com), an independent, nonpartisan site. Current as of Monday, November 9, 2026. https://iowafunnel.com/bills/91/HF14